ZA907420B - Method of rapidly radiolabelling monovalent antibody fragments with technetium - Google Patents

Method of rapidly radiolabelling monovalent antibody fragments with technetium

Info

Publication number
ZA907420B
ZA907420B ZA907420A ZA907420A ZA907420B ZA 907420 B ZA907420 B ZA 907420B ZA 907420 A ZA907420 A ZA 907420A ZA 907420 A ZA907420 A ZA 907420A ZA 907420 B ZA907420 B ZA 907420B
Authority
ZA
South Africa
Prior art keywords
monovalent antibody
antibody fragment
radiolabelling
technetium
solution
Prior art date
Application number
ZA907420A
Other languages
English (en)
Inventor
Hans J Hansen
J Hansen Hans
Anastasia Lentine-Jones
Lentine-Jones Anastasia
Original Assignee
Immunomedics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunomedics Inc filed Critical Immunomedics Inc
Publication of ZA907420B publication Critical patent/ZA907420B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A61K51/1048—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell determinant being a carcino embryonic antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1282—Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
ZA907420A 1989-09-18 1990-09-18 Method of rapidly radiolabelling monovalent antibody fragments with technetium ZA907420B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40824189A 1989-09-18 1989-09-18

Publications (1)

Publication Number Publication Date
ZA907420B true ZA907420B (en) 1991-07-31

Family

ID=23615452

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA907420A ZA907420B (en) 1989-09-18 1990-09-18 Method of rapidly radiolabelling monovalent antibody fragments with technetium

Country Status (15)

Country Link
EP (1) EP0419203B1 (fi)
JP (1) JPH0723326B2 (fi)
KR (1) KR960015611B1 (fi)
AT (1) ATE110281T1 (fi)
AU (1) AU640698B2 (fi)
CA (1) CA1340250C (fi)
DE (1) DE69011789T2 (fi)
DK (1) DK0419203T3 (fi)
ES (1) ES2063286T3 (fi)
FI (1) FI921146A0 (fi)
IE (1) IE64399B1 (fi)
IL (1) IL95723A (fi)
NO (1) NO920853D0 (fi)
WO (1) WO1991004056A1 (fi)
ZA (1) ZA907420B (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5346687A (en) * 1989-08-09 1994-09-13 Rhomed Incorporated Direct radiolabeling of antibody against stage specific embryonic antigen for diagnostic imaging
US5460785A (en) * 1989-08-09 1995-10-24 Rhomed Incorporated Direct labeling of antibodies and other protein with metal ions
US5443816A (en) * 1990-08-08 1995-08-22 Rhomed Incorporated Peptide-metal ion pharmaceutical preparation and method
EP0498333B1 (de) * 1991-02-05 1997-01-15 Cis Bio International Verfahren zur Herstellung einer mit Technetium-99m markierten organspezifischen Substanz
AU658403B2 (en) * 1991-02-27 1995-04-13 Akzo N.V. Technetium-99m labeling of proteins
ZA955642B (en) * 1994-07-07 1997-05-06 Ortho Pharma Corp Lyophilized imaging agent formulation
US5942210A (en) * 1994-11-15 1999-08-24 Cytogen Corporation Methods for lyoprotecting a macromolecule using tricine
US6080384A (en) * 1997-03-25 2000-06-27 American Biogenetic Sciences, Inc. Methods for radionuclide-labeling of biomolecules and kits utilizing the same
WO1999012579A1 (en) * 1997-09-08 1999-03-18 The General Hospital Corporation Imaging agents for early detection and monitoring of cardiovascular plaque
US7060251B1 (en) 1997-09-08 2006-06-13 The General Hospital Corporation Imaging agents for early detection and monitoring of cardiovascular plaque
EP1419786A1 (en) * 2002-11-13 2004-05-19 Bracco Imaging S.p.A. Method for the selective and quantitative functionalization of immunoglobulin fab fragments, conjugate compounds obtained with the same and compositions thereof
ITMI20022411A1 (it) * 2002-11-14 2004-05-15 Bracco Imaging Spa Agenti per la diagnosi e la terapia di tumori che espongono sulla superficie delle cellule proteine alterate.
JP2008503493A (ja) * 2004-06-17 2008-02-07 アナザオヘルス コーポレーション 腫瘍を破壊するための安定化され凍結乾燥された放射性薬剤
US7229603B2 (en) * 2004-06-17 2007-06-12 Anazaohealth Corporation Stablilized and lyophilized radiopharmaceutical agents
EP1894577A4 (en) * 2005-06-14 2012-03-28 Nihon Mediphysics Co Ltd RADIOACTIVE DIAGNOSTIC IMAGING DAY

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3725295A (en) * 1971-07-20 1973-04-03 Atomic Energy Commission Technetium labeling
US4057617A (en) * 1975-05-15 1977-11-08 Abramovici J Method of labeling proteins with technetium
US4062933A (en) * 1975-05-27 1977-12-13 Mallinckrodt, Inc. Colloidal compositions with protective agents suitable for radioactive labeling
US4323546A (en) * 1978-05-22 1982-04-06 Nuc Med Inc. Method and composition for cancer detection in humans
US4293537A (en) * 1978-09-05 1981-10-06 Wong Dennis W Novel chemical method of labeling proteins with 99m Tc-Technetium at physiological condition
US4472371A (en) * 1979-10-29 1984-09-18 Summa Medical Corporation Radiolabeled antibody to anti-tumor associated antigen and process
US4311688A (en) * 1979-10-29 1982-01-19 Serono Laboratories Inc. Composition and method for cancer detection in humans
USRE32417E (en) * 1979-10-29 1987-05-12 Summa Medical Corporation Radiolabeled antibody to anti-tumor associated antigen and process
US4401647A (en) * 1980-03-03 1983-08-30 The Regents Of The University Of Ca Radiolabeled neoglycopeptides
US4500507A (en) * 1981-10-30 1985-02-19 Wong Dennis W Diagnostic composition for radiologic imaging of neoplasms in the body and method of preparation
JPS5967228A (ja) * 1982-10-07 1984-04-16 Green Cross Corp:The 寒冷不溶性グロブリンの凍結乾燥方法
US4877868A (en) * 1986-03-12 1989-10-31 Neorx Corporation Radionuclide antibody coupling
WO1988007382A2 (en) * 1987-04-02 1988-10-06 Centocor Cardiovascular Imaging Partners, L.P. Method for labelling antibodies with a metal ion
US5061641A (en) * 1988-04-01 1991-10-29 Immunomedics, Inc. Method for radiolabeling proteins

Also Published As

Publication number Publication date
FI921146A (fi) 1992-03-17
IL95723A (en) 1995-08-31
FI921146A0 (fi) 1992-03-17
ES2063286T3 (es) 1995-01-01
NO920853L (no) 1992-03-04
DK0419203T3 (da) 1994-12-05
CA1340250C (en) 1998-12-15
NO920853D0 (no) 1992-03-04
IL95723A0 (en) 1991-06-30
ATE110281T1 (de) 1994-09-15
KR960015611B1 (ko) 1996-11-18
AU6521490A (en) 1991-04-18
KR920703111A (ko) 1992-12-17
AU640698B2 (en) 1993-09-02
IE64399B1 (en) 1995-08-09
EP0419203A1 (en) 1991-03-27
WO1991004056A1 (en) 1991-04-04
IE903360A1 (en) 1991-04-10
EP0419203B1 (en) 1994-08-24
JPH0723326B2 (ja) 1995-03-15
DE69011789D1 (de) 1994-09-29
JPH04505455A (ja) 1992-09-24
DE69011789T2 (de) 1994-12-15

Similar Documents

Publication Publication Date Title
ZA907420B (en) Method of rapidly radiolabelling monovalent antibody fragments with technetium
YU49170B (sh) Farmaceutska formulacija na bazi paratiroidnog hormona i raloksifena
EP0760685A4 (en) PROCESS FOR RADIOTHERING PROTEINS FOR THE PURPOSE OF PERFORMING RADIOIMMUNODETECTION AND RADIOIMMUNOTHERAPY BASED ON RADIONUCLEIDES
NO883926D0 (no) Fremgangsmaate for fremstilling av stabilisert humanproteinpreparat.
CA2167678A1 (en) Radioactive peptides
HK1062647A1 (en) Method and kit for imaging organs and tissues, using labelled antibodies
EP0403225A3 (en) Methods for technetium/rhenium labelling of proteins
DE69333110D1 (de) Mit dem cytotoxin von helicobacter pylori assoziiertes, immunodominantes antigen verwendbar in impfstoffen und zur diagnose
DE69412120T2 (de) Implantat-aufbau
DE3783745D1 (de) Verfahren zur herstellung einer mit technetium-99m-markierten organspezifischen substanz.
FR2297034B1 (fi)
DE69630727D1 (de) Radioaktiven Chitosankomplex und deren Anwendung in Strahlungstherapie
ATE88129T1 (de) Verfahren zur herstellung von aus kueken und gehaeuse bestehendem haehnchen fuer medizinische geraete.
Joiris et al. A new method for labelling of monoclonal antibodies and their fragments with technetium-99m
DE3688204D1 (de) Monoklonaler antikoerper gegen ein p21-bezuegliches dodekapeptid des ras-onkogens.
ATE96331T1 (de) Fr115224 enthaltende zusammensetzung fuer eine parenterale verabreichung.
AU1616488A (en) Protein absorption enhancing agents
EP0659764A3 (en) Peptides modified by a phosphine group for labeling with 99mTC and 186-188Re or paramagnetic agents.
IT1204775B (it) Kit per la determinazione dell'attivita' proliferativa nei tumori umani
DE69008859D1 (de) Modifizierte menschliche anti-rh(d)-antikörper.
UA19254A (uk) Спосіб діагhостики раку щитовидhої залози
CS33589A1 (en) Peptides with properties of hpv-virus protein's antigen determinant and method of their production